Tower Research Capital LLC (TRC) - PROCESSA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of PROCESSA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,524
-42.4%
10,094
+14.8%
0.00%
Q2 2023$4,380
+109400.0%
8,796
-1.3%
0.00%
Q1 2023$4
-55.6%
8,916
+8.5%
0.00%
Q4 2022$9
-99.9%
8,217
+80.0%
0.00%
Q3 2022$10,000
+150.0%
4,566
+219.5%
0.00%
Q2 2022$4,000
-55.6%
1,429
-54.4%
0.00%
Q1 2022$9,000
+12.5%
3,134
+94.3%
0.00%
Q4 2021$8,000
+166.7%
1,613
+586.4%
0.00%
Q1 2021$3,000
-66.7%
235
-82.5%
0.00%
Q4 2020$9,0001,3440.00%
Other shareholders
PROCESSA PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Solas Capital Management, LLC 196,150$961,0000.68%
AIGH Capital Management LLC 303,703$1,488,0000.45%
Worth Venture Partners, LLC 70,954$348,0000.17%
ESSEX INVESTMENT MANAGEMENT CO LLC 73,180$359,0000.04%
Verdence Capital Advisors LLC 63,227$310,0000.04%
Coastal Bridge Advisors, LLC 32,500$159,0000.03%
Vectors Research Management, LLC 4,000$20,0000.00%
Janney Montgomery Scott LLC 46,231$227,0000.00%
NORTHERN TRUST CORP 15,401$75,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of PROCESSA PHARMACEUTICALS INC shareholders